Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dimeo, F.
Right arrow Articles by Thiel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimeo, F.
Right arrow Articles by Thiel, E.
Related Collections
Right arrow 2004 - Editors Choice
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:1237-1242, 2004
© 2004 European Society for Medical Oncology

Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment

Background: Fatigue is a frequent and severe problem after treatment of patients with hematological malignancies. This symptom has been associated with anemia, reduced physical performance, mood, endocrine disorders and impaired nutritional status. Recently, it has been suggested that fatigue can be related to a persistent activation of the immune system with increased production of proinflammatory cytokines. However, there is no conclusive evidence regarding the role of the immune system in the origin of fatigue in cancer patients.

Patients and methods: We evaluated the correlation of fatigue with thyroid function, markers of immune activity [interleukin (IL)-1{alpha}, IL-1 soluble receptor, IL-6, C-reactive protein and neopterin], liver and kidney function, mood and physical ability in 71 patients with hematological malignancies. All patients had been free of relapse and not received treatment (chemotherapy, radiotherapy or immune modulators) for at least 3 months.

Results: Fatigue was related to depression (r=0.84; P<0.0001) and reduced performance status (r=–0.61; P<0.0001). However, there was no correlation between fatigue and thyroid, liver and kidney function, anemia, albumin concentration or markers of immune activity (all r-values <0.20; P>0.05).

Conclusions: We conclude that fatigue in relapse-free patients with hematological malignancies is associated with depressive mood and reduced physical performance, but not with impairment of thyroid function, anemia or persistent activation of the immune system.

F. Dimeo1,*, A. Schmittel2, T. Fietz2, S. Schwartz2, P. Köhler1, D. Böning1 and E. Thiel2

1 Institute of Sports Medicine and 2 Department of Hematology, Oncology and Transfusion Medicine, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

* Correspondence to: Dr F. Dimeo, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Station 06-Institute of Sports Medicine, Hindenburgdamm 30, 12200 Berlin, Germany. Tel: +49-30-8445-4767; Fax: +49-30-8445-1653; Email: fernondo.dimeo{at}chante.de

Key words: correlation analysis, fatigue, hematological malignancies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
F. Dimeo, S. Schwartz, N. Wesel, A. Voigt, and E. Thiel
Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment
Ann. Onc., April 1, 2008; (2008) mdn068v1.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Fouladiun, U. Korner, L. Gunnebo, P. Sixt-Ammilon, I. Bosaeus, and K. Lundholm
Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive Cachexia
Clin. Cancer Res., November 1, 2007; 13(21): 6379 - 6385.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
P. Jean-Pierre, C. D. Figueroa-Moseley, S. Kohli, K. Fiscella, O. G. Palesh, and G. R. Morrow
Assessment of Cancer-Related Fatigue: Implications for Clinical Diagnosis and Treatment
Oncologist, May 1, 2007; 12(suppl_1): 11 - 21.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.